What side effects and risks can occur when bupropion (Wellbutrin) is stopped abruptly in a hospitalized patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Abrupt Bupropion Discontinuation in Hospitalized Patients: Minimal Withdrawal Risk

Bupropion (Wellbutrin) can generally be stopped abruptly in hospitalized patients without significant withdrawal symptoms or serious adverse effects, though monitoring for mood changes and potential relapse of underlying depression is prudent.

Key Clinical Considerations

Withdrawal Profile

Unlike many antidepressants, bupropion does not produce a classic discontinuation syndrome. The available evidence, including FDA labeling and clinical guidelines, does not identify withdrawal symptoms as a significant concern when stopping bupropion 1. This distinguishes it from SSRIs and SNRIs, which commonly cause discontinuation syndromes.

What to Monitor When Stopping Bupropion

Primary concerns when discontinuing bupropion in hospital:

  • Return of depressive symptoms: The underlying condition may re-emerge, particularly if bupropion was effectively treating depression 2
  • Increased smoking urges: If the patient was using bupropion for smoking cessation, nicotine cravings may return 2
  • Mood destabilization: Watch for worsening depression, anxiety, or irritability related to loss of therapeutic effect rather than true withdrawal 2

Important Context: High Relapse Rates After Discontinuation

One guideline specifically notes that patients with schizophrenia treated with bupropion plus combination therapy "demonstrated a high relapse rate after discontinuation of treatment" 2. This reflects loss of therapeutic benefit rather than withdrawal toxicity, but underscores the importance of monitoring mood and psychiatric symptoms after stopping the medication.

Seizure Risk Considerations

Critical safety point: The primary concern with bupropion in hospitalized patients relates to continuing the medication, not stopping it. Bupropion lowers the seizure threshold (0.1% risk) and should be discontinued in patients with 2:

  • New seizures or seizure history
  • Brain metastases or structural brain lesions
  • Stroke
  • Conditions that may increase seizure risk

Paradoxically, stopping bupropion may reduce seizure risk in vulnerable hospitalized patients, making discontinuation potentially beneficial in certain clinical scenarios 3, 4.

Contrast with Alcohol/Benzodiazepine Withdrawal

The FDA label explicitly warns that "excessive use or abrupt discontinuation of alcohol, benzodiazepines, antiepileptic drugs, or sedatives/hypnotics can increase the risk of seizure" in patients taking bupropion 1. This refers to the interaction between bupropion and withdrawal from other substances—not withdrawal from bupropion itself.

Notably, bupropion toxicity can actually mimic alcohol withdrawal syndrome with agitation, tremors, hypertension, and hallucinations 5, but this is an overdose phenomenon, not a withdrawal effect.

Practical Hospital Management

When discontinuing bupropion in hospitalized patients:

  1. No taper required: Can stop abruptly without dose reduction
  2. Monitor for 48-72 hours for:
    • Worsening depression or suicidal ideation
    • Increased anxiety or agitation
    • Return of symptoms that bupropion was treating
  3. Document reason for discontinuation (e.g., seizure risk, drug interaction, patient preference)
  4. Plan for outpatient follow-up to address underlying psychiatric condition

Special Populations

Patients with depression: Longer duration of bupropion treatment helps prevent relapse in those who successfully quit smoking 2. Abrupt hospital discontinuation may precipitate depressive relapse, requiring close psychiatric monitoring and potential alternative antidepressant therapy.

Combination therapy: If patient was on bupropion plus naltrexone (Contrave), stopping may precipitate return of appetite and weight gain, but no specific withdrawal syndrome is documented 3.

Common Pitfalls to Avoid

  • Don't confuse bupropion discontinuation with SSRI discontinuation syndrome: Bupropion's dopaminergic/noradrenergic mechanism differs fundamentally from serotonergic antidepressants
  • Don't assume all antidepressants require tapering: The evidence does not support this for bupropion
  • Don't overlook the reason bupropion was prescribed: The underlying condition (depression, smoking cessation) may worsen, which is different from withdrawal
  • Don't restart bupropion if patient had a seizure: This is an absolute contraindication 2

References

2
Guideline

smoking cessation, version 1.2016, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

Related Questions

What is the likelihood of developing an allergic reaction to bupropion (Wellbutrin) nine days after starting therapy?
What are the side effects and serious adverse events associated with Wellbutrin (bupropion)?
Can Wellbutrin (bupropion) cause visual or auditory hallucinations?
Can bupropion cause a cough as a side effect?
Are there any concerns with taking Wellbutrin (bupropion) while smoking cigarettes?
What is the preferred second‑line therapy for an adult with metastatic renal cell carcinoma that has progressed on first‑line ipilimumab (CTLA‑4 inhibitor) plus nivolumab (PD‑1 inhibitor)?
With a blood pressure of 110/69 mmHg, can I take mirtazapine 7.5 mg?
In otherwise healthy adolescents and adults, how long does a concussion typically take to resolve?
Is cyclobenzaprine a benzodiazepine or an NSAID?
In a patient receiving mannitol with a serum potassium of 3.38 mEq/L, is aggressive correction required?
In a mother who has delivered triplets by cesarean section, what are the postoperative risks, how should management be altered—especially regarding oxytocin infusion—and what recommendations are there for breastfeeding?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.